Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Spain / NCT07499973
Recruiting Not applicable

Influence of Abdominal Muscle Function on Knee Stability for Injury Prevention

NCT07499973 · tracked via the Priya Life Science Spain tracker
Phase
Not applicable
Started
2026-03-06
Last updated
2026-03-30

Condition(s) studied

Core StrengthKnee Stability

Investigational drug(s) / intervention(s)

Core Stabilization Training Program

Core Stabilization Training Program: Participants will perform the following exercises for 8 weeks: Front plank: 2 × 30 seconds (with progression including alternating leg lifts) Side plank: 2 × 30 seconds per side (with progression including hip abduction) Nordic hamstring exercise: 2 sets of 3-15 repetitions depending on progression Rest between sets: 30-60 seconds based on perceived exertion. All exercises are performed under supervision prior to regular training sessions.

Study summary

The goal of this clinical trial is to learn whether an 8-week core stabilization training program can improve abdominal strength and knee stability in physically active women aged 18 to 35. The main questions it aims to answer are:

Does core stabilization training improve abdominal endurance as measured by the Prone Bridge Test? Does this training enhance knee stability as measured by the Lateral Squat Down, Y-Balance Test, and Drop Vertical Jump?

Researchers will compare participants' results before and after the intervention to see whether the training program leads to measurable improvements in strength and stability.

Participants will:

Complete baseline testing of abdominal strength and knee stability using standardized assessments (Prone Bridge Test, Lateral Squat Down, Y-Balance Test, Drop Vertical Jump) recorded with a Vicon motion-capture system.

Perform an 8-week supervised core stabilization program that includes front plank, side plank, and Nordic hamstring exercises following a structured progression.

Complete the same performance tests again after the intervention.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
35 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Female participants * Age between 18 and 35 years * Performing regular physical activity ≥ 6 hours per week. * Able to complete all assessment procedures (Prone Bridge Test, Lateral Squat Down, Y-Balance Test, Drop Vertical Jump). * Willing to comply with the 8-week study procedures (training program or control condition) Exclusion Criteria: * Current musculoskeletal injury affecting the lower limbs, trunk, or spine * History of surgery in the lower limbs or spine in the past 12 months * Known neurological, cardiovascular, or systemic conditions that may interfere with physical testing * Pregnancy * Participation in any structured core-strengthening program during the study period * Inability to abstain from core training if assigned to the control group

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Universidad Europea de Madrid Villaviciosa de Odón Madrid Recruiting

More European University of Madrid trials in Spain

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07499973 on ClinicalTrials.gov ↗ ← All trials in Spain